Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

MCPHS University

Alzheimers Disease: Current and Emerging Treatments

Access Activity

Overview / Abstract:

Alzheimer's disease is the sixth leading cause of death in the United States, and the fifth leading cause of death for those 65 years and older. It is estimated that 5.7 million Americans of all ages are living with Alzheimer’s in 2018. By 2025, the number of people 65 and older affected by this disease is expected to reach 7.1 million. Without the development of medical breakthroughs, this number will increase to 13.8 million by 2050.
There are many barriers and challenges to treatment of Alzheimer’s disease. Timely diagnosis is required in order to provide symptom relief as soon as possible. Currently, there are no treatments proven to prevent or cure cognitive decline. There are also dose limits based on side effects of current treatments. Although novel therapies are being investigated, there is a deficit in the pipeline. The failure rate for Alzheimer’s drugs in development is over 99% and with high risk in development, the critical need for an increased drug development effort is urgent.
Overall, this course is intended to cover current treatment guidelines as well as introduce newer treatment approaches presently being researched.

Learning Objectives
-Upon completion of this activity, the participant should be able to:
-Define Alzheimer's disease, describe its symptoms, and resultant -changes in the brain.
-Name current treatments for cognitive decline, and behavioral symptoms and mood disorders associated with Alzheimer’s disease.
-Identify investigational treatments for Alzheimer’s disease, including disease modifying therapies and symptomatic treatments
-Explain the ways in which current Alzheimer’s treatments help improve symptoms in patients, as well as the ways in which the pipeline needs improvement.


Jun 13, 2019


Pharmacy CPE



Credits / Hours

1 contact hour (0.1 CEUs)



Presenters / Authors / Faculty

Maria Cusano, PharmD - Postdoctoral fellow
MCPHS University/Novartis

Florence Egri, PharmD - Postdoctoral fellow
MCPHS University/Takeda Oncology

Olivia Grover, PharmD - Postdoctoral fellow
MCPHS University/Sanofi-Genzyme

Activity Specialities / Related Topics

Alzheimers / Dementia

Keywords / Search Terms

MCPHS University , Pharmacy, Alzheimer's

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.